Literature DB >> 20665131

Virus infections: lessons from pancreas histology.

Francesco Dotta1, Letizia Galleri, Guido Sebastiani, Francesco Vendrame.   

Abstract

Type 1 diabetes mellitus is a chronic autoimmune disease resulting from the progressive immune-mediated destruction of pancreatic beta cells in genetically susceptible individuals, with the likely contribution of environmental factors, among which viruses have been extensively studied. The pathologic hallmark of the disease is insulitis-a process characterized by islet infiltration of immunocompetent cells that has been well characterized in animal models of islet autoimmunity, and to a lesser extent, in humans. Insulitis characterization has provided valuable information to gain insights into the disease pathogenesis. We review the recent literature on the viral contribution to beta-cell destruction and dysfunction in type 1 diabetes, with particular reference to the pathology of the pancreatic islet in humans and in animal models of the disease.

Entities:  

Mesh:

Year:  2010        PMID: 20665131     DOI: 10.1007/s11892-010-0137-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  41 in total

Review 1.  Type 1 diabetes: recent developments.

Authors:  Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal:  BMJ       Date:  2004-03-27

2.  Interferon stimulates the expression of 2',5'-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells.

Authors:  V Bonnevie-Nielsen; A M Gerdes; J Fleckner; J S Petersen; B Michelsen; T Dyrberg
Journal:  J Interferon Res       Date:  1991-10

3.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study.

Authors:  M Lönnrot; K Korpela; M Knip; J Ilonen; O Simell; S Korhonen; K Savola; P Muona; T Simell; P Koskela; H Hyöty
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

5.  OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.

Authors:  L Leigh Field; Vagn Bonnevie-Nielsen; Flemming Pociot; Shao Lu; Thomas B Nielsen; Henning Beck-Nielsen
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

6.  Rat pancreatic beta cells and cytomegalovirus infection.

Authors:  Maaike J Smelt; Marijke M Faas; Bart J de Haan; Jeroen Hofstede; Chi-Wai Cheung; Hanna van der Iest; Aalzen de Haan; Paul de Vos
Journal:  Pancreas       Date:  2010-01       Impact factor: 3.327

7.  Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.

Authors:  Joana Côrte-Real; Nádia Duarte; Luís Tavares; Carlos Penha-Gonçalves
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

8.  In vitro infection of mouse pancreatic islet cells with coxsackie viruses.

Authors:  S A Bopegamage; A Petrovicová
Journal:  Acta Virol       Date:  1994-10       Impact factor: 1.162

9.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

10.  Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.

Authors:  M Li; D-J Zheng; L L Field; V Bonnevie-Nielsen
Journal:  Exp Diabetes Res       Date:  2009-10-29
View more
  5 in total

Review 1.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 2.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function.

Authors:  F A Grieco; G Sebastiani; I Spagnuolo; A Patti; F Dotta
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

3.  α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Authors:  Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

4.  A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.

Authors:  Ricardo C Ferreira; Hui Guo; Richard M R Coulson; Deborah J Smyth; Marcin L Pekalski; Oliver S Burren; Antony J Cutler; James D Doecke; Shaun Flint; Eoin F McKinney; Paul A Lyons; Kenneth G C Smith; Peter Achenbach; Andreas Beyerlein; David B Dunger; David G Clayton; Linda S Wicker; John A Todd; Ezio Bonifacio; Chris Wallace; Anette-G Ziegler
Journal:  Diabetes       Date:  2014-02-21       Impact factor: 9.461

5.  Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes.

Authors:  Niels Busse; Federico Paroni; Sarah J Richardson; Jutta E Laiho; Maarit Oikarinen; Gun Frisk; Heikki Hyöty; Eelco de Koning; Noel G Morgan; Kathrin Maedler
Journal:  Oncotarget       Date:  2017-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.